Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study

Abstract

OBJECTIVE: Primary aldosteronism (PA) is characterized by the onset of both cardiac and gluco-metabolic alterations. The aim of this study was to evaluate the impact of aldosterone excess on the development of such complications, and the effects of surgical and pharmacological treatment on their long-term outcome. METHODS: We prospectively re-examined 61 patients: 25 with aldosterone-producing adenoma (APA), after surgery, and 36 patients with idiopathic hyperaldosteronism (IHA) on pharmacological treatment. The lipid, fasting and dynamic glucose profiles and the echocardiographic parameters were evaluated at diagnosis and at follow-up. RESULTS: After adrenalectomy all patients had normalization of aldosterone levels and were cured of hypokalaemia, and a resolution of hypertension was achieved in 12 of 25 patients. APA patients showed a significant reduction of both plasma glucose (P=0.017) and insulin levels (P=0.001) after 75 g oral glucose tolerance test. Stabilization of glucose metabolism complications was observed in IHA patients. Multiple regression analysis at diagnosis showed a positive correlation between homeostasis model assessment (HOMA) insulin resistance index and HOMA beta cell and serum aldosterone levels in both APA and IHA. Echocardiographic parameters were improved in both APA and IHA at follow-up and the difference was statistically significant for left ventricular mass index (P=0.017) and interventricular septum thickness (P=0.007) in APA patients. CONCLUSIONS: The removal of aldosterone excess in APA patients induces the regression of both cardiac and gluco-metabolic complications, indicating aldosterone as a main determinant of such alterations. In IHA patients the medical treatment seems to avoid the possible progression of the these alterations that appear to be stable.

Overview

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3280108e6f

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Cited by

See all 196

Metadata

Authors
Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M.
Affiliations
  • Marche Polytechnic University (IT)
  • University of Padua (IT)
Corresponding author
Giacchetti, Gilberta
Venue
Journal of Hypertension
Published
2007-01
Volume
25
Issue
1
Pages
177-186
ISSN
0263-6352 (ISSN-L)
OpenAlex
W1992509588
Cited by
196
References
42
Citations by year
2026: 6 · 2025: 6 · 2024: 5 · 2023: 5 · 2022: 11 · 2021: 7 · 2020: 11 · 2019: 11 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 13 · 2014: 7 · 2013: 13 · 2012: 20
FWCI
9.10
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
primary aldosteronism, aldosterone, cardiometabolic syndrome, aldosterone-producing adenoma, idiopathic hyperaldosteronism, adrenalectomy, insulin resistance, beta-cell function, glucose metabolism, left ventricular hypertrophy, hypertension, hypokalemia, mineralocorticoid receptor antagonists
MeSH terms
Adenoma, Adrenal Gland Neoplasms, Adrenalectomy, Aldosterone, Mineralocorticoid Receptor Antagonists, Antihypertensive Agents, Blood Glucose, Blood Pressure, Female, Follow-Up Studies, Heart Diseases, Humans, Hyperaldosteronism, Hypertension, Insulin, Insulin Resistance, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Renin-Angiotensin System, Time Factors, Linear Models, Ventricular Function, Left, Glucose Metabolism Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. https://app.cochat.ai/papers/10.1097/hjh.0b013e3280108e6f
The paper
Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007). Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3280108e6f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.